Management of pseudoaneurysm associated with endovascular treatments at third level
Main Article Content
Keywords
Aneurysm, False, Thrombin, Vascular Surgical Procedures
Abstract
Background: Pseudoaneurysms occur when the wall of a blood vessel is injured and the leaking blood accumulates in the surrounding tissue, with a prevalence of 0.5–2%. Their etiology is mainly associated with arterial puncture, needle and introducer size, use of ultrasound (US), duration or complexity of the procedure, as well as the use of anticoagulation and closure devices. Risk factors include age ≥ 75 years, female sex, chronic kidney disease, systemic arterial hypertension (SAH), type 2 diabetes mellitus (T2DM), cardiac arrhythmia, infected tissues, and multiple puncture attempts.
Objective: To analyze management protocols for pseudoaneurysms secondary to endovascular procedures in a tertiary care unit in western Mexico.
Materials and methods: Analytical cross-sectional study with a longitudinal component. Electronic medical records and US reports with a diagnosis of pseudoaneurysm in patients undergoing endovascular procedures were reviewed from January 1 to December 31, 2022. A p value ≤ 0.05 was considered statistically significant.
Results: Forty-eight patients were evaluated: Group 1 (conservative treatment, n = 27) and Group 2 (invasive treatment, n = 21). Group 2 vs. Group 1: mean age (62.67 ± 16.93 vs. 66.48 ± 11; p = 0.018). Procedures included cardiac catheterization, peripheral angioplasty, and transcatheter aortic valve implantation (TAVI). Time (days) to referral for evaluation (158 ± 34.4 vs. 6.86 ± 1.32; p = 0.032); femoral access (62% vs. 52%; p = 0.125); sac size ≥ 3 cm (81% vs. 22%; p = 0.001).
Conclusions: Fifty-six percent resolved with conservative management and 44% required invasive treatment. Associated factors were sac diameter ≥ 3 cm and ≥ 30 days to request angiologic evaluation.
References
1. Rao SV, O’Donoghue ML, Ruel M, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025. doi: 10.1161/CIR.0000000000001309.
2. Barker CM, Dahm C. Femoral Access, Hemostasis, and Complications for Transcatheter Aortic Valve Replacement. Interv Cardiol Clin. 2021;10:423-430. doi: 10.1016/j.iccl.2021.07.001.
3. Rivera PA, Dattilo JB. Pseudoaneurysm. 2024. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31194401.
4. Watanabe S, Kanazawa R, Uchida T, et al. Endovascular Embolization of Femoral Pseudoaneurysm Associated with Therapeutic and Diagnostic Neuroendovascular Procedures. J Neuroendovasc Ther. 2023;17:8-14. doi: 10.5797/jnet. oa.2022-0048.
5. Tulla K, Kowalski A, Qaja E. Femoral Artery Pseudoaneurysm. 2022. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.
6. Pino R, Casati R, Lo Giudice F, et al. Iatrogenic arterial pseudoaneurysms: treatment or prevention? Minerva Cardioangiol. 2020;68:268-270. doi: 10.23736/S0026-4725.20.05264-0.
7. Sokhal BS, Ma Y, Rajagopalan S. Femoral artery aneurysms. Br J Hosp Med (Lond). 2022;83(12):1-10. doi: 10.12968/hmed.2022.0258.
8. Bansal A, Gorsi U, Farook S, et al. Interventional radiology management of extremity pseudoaneurysms: a pictorial essay. Emerg Radiol. 2021;28:1029-1039. doi: 10.1007/s10140-021-01939-w.
9. Abou Diwan R, Kaadi L, Hachem S, et al. Pseudoaneurysms: Different ultrasound patterns, aetiologies and locations. Australas J Ultrasound Med. 2023;26:258-266. doi: 10.1002/ajum.12348.
10. Hayakawa N, Kodera S, Miyauchi A, et al. Effective treatment of iatrogenic femoral pseudoaneurysms by combined endovascular balloon inflation and percutaneous thrombin injection. Cardiovasc Interv Ther. 2022;37:158-166. doi: 10.1007/s12928-021-00764-9.
11. Wu H, Zhang L, Zhang C, et al. Non-Surgical treatment Versus Surgery for Iatrogenic Femoral Artery Pseudoaneurysms: Systematic Review and Meta-Analysis. Front Surg. 2022;9:905701. doi: 10.3389/fsurg.2022.905701.
12. Yadav R, Sharma A, Pathak S. Successful Surgical Management of Post-traumatic Superficial Femoral Artery Pseudoaneurysm with Delayed Presentation. Cureus. 2023;15:e45739. doi: 10.7759/cureus.45739.
13. Patel RK, Alagappan A, Tripathy T, et al. Lower extremity pseudoaneurysms and their interventional radiological management: a pictorial review. Emerg Radiol. 2023;30:555- 561. doi: 10.1007/s10140-023-02151-8.
14. Kim KW, Lee C, Im G, et al. Optimal thrombin injection method for the treatment of femoral artery pseudoaneurysm. J Thromb Haemost. 2024;22(5):1389-1398. doi: 10.1016/j.jtha.2023.12.040.
15. Koza Y, Kaya U. Retrospective Analysis of 120 Cases of Iatrogenic and Traumatic Peripheral Arterial Pseudoaneurysms. Eurasian J Med. 2020;52:180-184. doi: 10.5152/eurasianjmed.2019.18422.
16. Kurzawski J, Janion-Sadowska A, Zandecki L, et al. Comparison of the Efficacy and Safety of Two Dosing Protocols for Ultrasound Guided Thrombin Injection in Patients with Iatrogenic Femoral Pseudoaneurysms. Eur J Vasc Endovasc Surg. 2020;59:1019-1025. doi: 10.1016/j. ejvs.2020.01.009.
17. Huang X, Cai H, Lu SY. Iatrogenic femoral artery pseudoaneurysm surgically repaired with combined bovine pericardial roll and autologous great saphenous vein grafts. Chin J Traumatol. 2021;24(2):75-78. doi: 10.1016/j. cjtee.2020.11.001.
18. Yamazaki D, Fujihashi T, Amamizu H, et al. VIABAHN® Stent Graft Implantation for Iatrogenic Arteriovenous Fistula and Pseudoaneurysm of the Deep Femoral Artery. Case Rep Cardiol. 2024;2024:3426669. doi: 10.1155/2024/3426669.
19. Zhang HY, Chai DZ. Iatrogenic Femoral Arteriovenous Fistula and Pseudoaneurysm. Eur J Vasc Endovasc Surg. 2024;68(2):179. doi: 10.1016/j.ejvs.2024.03.020.
20. Wang Y, Zheng H, Yao W, et al. Management of traumatic peripheral artery pseudoaneurysm: A 10-year experience at a single center. J Interv Med. 2022;6:29-34. doi: 10.1016/j. jimed.2022.10.002.
21. Yang EY, Tabbara MM, Sanchez PG, et al. Comparison of Ultrasound-Guided Thrombin Injection of Iatrogenic Pseudoaneurysms Based on Neck Dimension. Ann Vasc Surg. 2018;47:121-127. doi: 10.1016/j.avsg.2017.07.029.
22. Watanabe S, Kanazawa R, Uchida T, et al. Endovascular Embolization of Femoral Pseudoaneurysm Associated with Therapeutic and Diagnostic Neuroendovascular Procedures. J Neuroendovasc Ther. 2023;17:8-14. doi: 10.5797/jnet. oa.2022-0048
23. Gorecka J, Chen JF, Shah S, et al. A hybrid approach for vascular control and repair of an expanding iatrogenic femoral artery pseudoaneurysm. J Vasc Surg Cases Innov Tech. 2020;6:460-463. doi: 10.1016/j.jvscit.2020.07.010.
24. Gummerer M, Kummann M, Gratl A, et al. Ultrasound-Guided Fibrin Glue Injection for Treatment of Iatrogenic Femoral Pseudoaneurysms. Vasc Endovascular Surg. 2020;54:497- 503. doi: 10.1177/1538574420934631.
25. Saydam O, Serefli D, Engin AY, et al. Ultrasound-guided thrombin injection for treatment of iatrogenic femoral artery pseudoaneurysms compared with open surgery: first experiences from a single institution. Ann Surg Treat Res. 2020;98:270-276. doi: 10.4174/astr.2020.98.5.270
26. Kurzawski J, Piątek Ł, Zandecki Ł, et al. Ultrasound-guided thrombin injection as a preferable method of treatment for iatrogenic pseudoaneurysms after invasive cardiovascular procedures - a single-center experience. Postepy Kardiol Interwencyjnej. 2021;17:376-380. doi: 10.5114/aic.2021.111039.xx
27. Cho HJ, Jeon CH, Kim MH, et al. Ultrasonography-guided endovascular management of femoral artery pseudoaneurysm after unintended dialysis catheterization with suture-mediated vascular closure devices. J Vasc Access. 2024;25:2031- 2035. doi: 10.1177/11297298221130895.
28. Maeno R, Taniguchi R, Suhara M, et al. Area reduction of perforation with a small-size sheath technique for iatrogenic femoral artery pseudoaneurysm with a large perforation. J Vasc Surg Cases Innov Tech. 2023;9:101235. doi: 10.1016/j. jvscit.2023.101235.
29. Oka S, Fumimoto M, Noguchi S, et al. Managing Femoral Artery Pseudoaneurysm Using Snare-Guided Through-and-Through Access With Perclose ProGlide. Cureus. 2025;17:e77650. doi: 10.7759/cureus.77650.
30. Wischmann P, Stern M, Baasen S, et al. Importance of pseudoaneurysms after TAVI - a retrospective analysis of 2063 patients. Vasa. 2025;54:50-58. doi: 10.1024/0301-1526/a001135
31. Grundmann D, Rudolph T, Adam M, et al. Procedural and Clinical Outcomes According to Ultrasound-Guided Access in TAVI: A Propensity-Matched Comparative Subanalysis From the PULSE Registry. Circ Cardiovasc Interv. 2025;18:e014771. doi: 10.1161/CIRCINTERVENTIONS.124.014771.
32. Mayer K, Gewalt S, Morath T, et al. Comparison of Vascular Closure Devices vs Manual Compression After Femoral Artery Puncture in Patients on Oral Anticoagulation - Post Hoc Analysis of the ISAR-CLOSURE Trial. J Invasive Cardiol. 2021;33(9):E709-E715. doi: 10.25270/jic/21.00081.
33. Nørgaard MW, Færch J, Joshi FR, et al. Is It Safe to Mobilize Patients Very Early After Transfemoral Coronary Procedures? (SAMOVAR): A Randomized Clinical Trial. J Cardiovasc Nurs. 2022;37(5):E114-E121. doi: 10.1097/JCN.0000000000000845.
34. Strauss SA, Ma GW, Seo C, et al. Ultrasound-guided versus anatomic landmark-guided percutaneous femoral artery access. Cochrane Database Syst Rev. 2025;3(3):CD014594. doi: 10.1002/14651858.CD014594.pub2
35. Fishkin T, Isath A, Virk HUH, et al. Ultrasound Guidance for Vascular Access for Coronary Angiogram: A Meta-Analysis of Randomized Controlled Trials. Am J Cardiol. 2023;206:70- 72. doi: 10.1016/j.amjcard.2023.08.014.
